Aurobindo Pharma’s arm recalls over 1.5 million injections from US market

10 May 2018 Evaluate

Aurobindo Pharma’s US subsidiary - Auromedics Pharma LLC has initiated voluntary recall of over 1.5 million bags of different antibiotic and anti-seizure injections from the US market due to lack of assurance of sterility.

The company started recalling nearly 0.4 million bags of Linezolid Injection 600 mg per 300 mL (2 mg/mL) for Intravenous Administration, 0.67 million bags of Levofloxacin in 5 % Dextrose Injection of different strengths and 0.52 million of Levetiracetam of different strengths.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Aurobindo Pharma Share Price

1133.15 -12.45 (-1.09%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×